1000-7431
2013 Issue 4
The effects of HPV16 E6 on active release of high mobility group box-B1 and the invasion ability of cervical cancer cells
WANG Jing 1 ; LI Wei 2 ; CAI Hong-bing 3 ; CHENG Xin 3 1. Department of Gynecology and Obstetrics; Xiangyang Central Hospital; Xiangyang 441021; Hubei Province; China; 2. Department of Gynecology and Obstetrics; Xiangyang NO.1 People’s Hospital & Affiliated Xiangyang Hospital of Hubei University of Medicine; Xiangyang 441000; Hubei Province; China; 3. Department of Gynecologic Oncology of Zhongnan Hospital of Wuhan University; Hubei Cancer Clinical Study Center; Hubei Key Laberatory of Tumor Biological Behaviors; Wuhan 430071; Hubei Province; China
WANG Jing 1 ; LI Wei 2 ; CAI Hong-bing 3 ; CHENG Xin 3 1. Department of Gynecology and Obstetrics; Xiangyang Central Hospital; Xiangyang 441021; Hubei Province; China; 2. Department of Gynecology and Obstetrics; Xiangyang NO.1 People’s Hospital & Affiliated Xiangyang Hospital of Hubei University of Medicine; Xiangyang 441000; Hubei Province; China; 3. Department of Gynecologic Oncology of Zhongnan Hospital of Wuhan University; Hubei Cancer Clinical Study Center; Hubei Key Laberatory of Tumor Biological Behaviors; Wuhan 430071; Hubei Province; China
..............page:309-313
Clinical observation on change of immunological function after chemotherapy in combination with ubenimex for malignant tumors
XIA Jun-xian; ZHU Mei-qin; CHEN Jing-hua; XU Rui-lian; TIAN Zhong-kai; SHEN Wei-xi Department of Medical Oncology; Shenzhen People’s Hospital; Second Clinical Medical College; Jinan University; Shenzhen 518020; Guangdong Province; China
XIA Jun-xian; ZHU Mei-qin; CHEN Jing-hua; XU Rui-lian; TIAN Zhong-kai; SHEN Wei-xi Department of Medical Oncology; Shenzhen People’s Hospital; Second Clinical Medical College; Jinan University; Shenzhen 518020; Guangdong Province; China
..............page:382-384
..............page:333
Effect of high-altitude exposure on safety of complete video-assisted thoracoscopic surgery lobectomy in elderly patients with non-small cell lung cancer and analysis of prognosis
GUAN Lin; HONG Wen-juan; HONG Zhi-peng; HUANG Tao First Affiliated Hospital of Kunming Medical University; Department of Thoracic Surgery; Kunming 650032; Yunnan Province; China
GUAN Lin; HONG Wen-juan; HONG Zhi-peng; HUANG Tao First Affiliated Hospital of Kunming Medical University; Department of Thoracic Surgery; Kunming 650032; Yunnan Province; China
..............page:327-333
..............page:386-390
Association of single nucleotide polymorphism in untranslated region of EGFR gene with genetic susceptibility of gastric cancer
ZHANG Jun-feng 1; 2 ; ZHANG Chun-bing 3 ; YAO Xue-quan 4 ; YANG Ya-ping 1 ; WU Juan 1 ; YANG Xue- wen 3 ; ZHAO Wang-sheng 5 ; TONG Shu-juan 1; 2 ; QIU Hong 6 ; ZHAN Zhen 1; 2 1. Department of Pathogen and Immunology; College of Basic Medicine; Nanjing University of Chinese Medicine; Nanjing 210023; Jiangsu Province; China; 2. Department of Chinese and Western Integrative Medicine; Nanjing University of Chinese Medicine; Nanjing 210023; Jiangsu Province; China; 3. Department of Clinical Laboratory; Jiangsu Provincial Hospital of Traditional Chinese Medicine; Nanjing 210029; Jiangsu Province; China; 4. Department of Surgery for Tumors of Digestive System; Jiangsu Provincial Hospital of Traditional Chinese Medicine; Nanjing 210029; Jiangsu Province; China; 5. Department of Clinical Laboratory; Jiangsu Province People’s Hospital; Nanjing 210029; Jiangsu Province; China; 6. Department of Clinical Laboratory; Chinese People’s Liberation Army Bayi Hospital of Nanjing; Nanjing 210002; Jiangsu Province; China
ZHANG Jun-feng 1; 2 ; ZHANG Chun-bing 3 ; YAO Xue-quan 4 ; YANG Ya-ping 1 ; WU Juan 1 ; YANG Xue- wen 3 ; ZHAO Wang-sheng 5 ; TONG Shu-juan 1; 2 ; QIU Hong 6 ; ZHAN Zhen 1; 2 1. Department of Pathogen and Immunology; College of Basic Medicine; Nanjing University of Chinese Medicine; Nanjing 210023; Jiangsu Province; China; 2. Department of Chinese and Western Integrative Medicine; Nanjing University of Chinese Medicine; Nanjing 210023; Jiangsu Province; China; 3. Department of Clinical Laboratory; Jiangsu Provincial Hospital of Traditional Chinese Medicine; Nanjing 210029; Jiangsu Province; China; 4. Department of Surgery for Tumors of Digestive System; Jiangsu Provincial Hospital of Traditional Chinese Medicine; Nanjing 210029; Jiangsu Province; China; 5. Department of Clinical Laboratory; Jiangsu Province People’s Hospital; Nanjing 210029; Jiangsu Province; China; 6. Department of Clinical Laboratory; Chinese People’s Liberation Army Bayi Hospital of Nanjing; Nanjing 210002; Jiangsu Province; China
..............page:321-326
Anvances in research on Raf kinase inhibitory protein in common digestive system malignant tumors
YU Min;L Nong-hua Department of Gestroenterology; First Affiliated Hospital of Nanchang University; Nanchang 330006; Jiangxi Province; China
YU Min;L Nong-hua Department of Gestroenterology; First Affiliated Hospital of Nanchang University; Nanchang 330006; Jiangxi Province; China
..............page:378-381
Comparison of the influnce of gefitinib treatment on quality of life between non-small cell lung cancer patients with high and low ECOG-PS score
FU Juan 1 ; CHEN Zhen-dong 1 ; WEI Fen-fen 1 ; SONG Geng 1 ; DING Wei 2 1. Center of Medical Oncology; Second Affiliated Hospital of Anhui Medical University; Hefei 230601; Anhui Province; China; 2. Department of Oncology; Anhui Provincial Xin’an Hospital; Hefei 230061; Anhui Province; China
FU Juan 1 ; CHEN Zhen-dong 1 ; WEI Fen-fen 1 ; SONG Geng 1 ; DING Wei 2 1. Center of Medical Oncology; Second Affiliated Hospital of Anhui Medical University; Hefei 230601; Anhui Province; China; 2. Department of Oncology; Anhui Provincial Xin’an Hospital; Hefei 230061; Anhui Province; China
..............page:339-344
Expression of pyruvate kinase isoform M2 and its relationship with BRAF mutation in papillary thyroid carcinoma
ZHANG Wei 1 ; WANG Cui-fang 2 ; GUAN Hai-xia 3 1 . Department of Endocrinology ; Shengjing Hospital ; China Medical University ; Shenyang 110004 ; Liaoning Province; China; 2. Department of Pathology; Fengtian Hospital; Shenyang Medical College; Shenyang 110024; Liaoning Province; China; 3. Department of Endocrinology; First Affiliated Hospital; China Medical University; Shenyang 110001; Liaoning Province; China
ZHANG Wei 1 ; WANG Cui-fang 2 ; GUAN Hai-xia 3 1 . Department of Endocrinology ; Shengjing Hospital ; China Medical University ; Shenyang 110004 ; Liaoning Province; China; 2. Department of Pathology; Fengtian Hospital; Shenyang Medical College; Shenyang 110024; Liaoning Province; China; 3. Department of Endocrinology; First Affiliated Hospital; China Medical University; Shenyang 110001; Liaoning Province; China
..............page:350-354
The efficacy and safety of high-dose adjuvant chemotherapy with paclitaxel and thiotepa in postoperative breast cancer patients with high risk of recurrence
SHAO Bin; YU Jing; ZHU Yu-lin; ZHANG Jie; JIANG Han-fang; DI Li-jun; SONG Guo-hong; ZHU Bu- dong; CHE Li; JIA Jun; LIANG Xu; WANG Chao-ying; YAN Ying; Lü Min; LIN Xiao-lin; HUANG Xiao-lei; YOU Miao-ning; WANG Xiao-li; ZHOU Xin-na; REN Jun Department of Breast Oncology; Beijing Cancer Hospital & Beijing Institute for Cancer Research; Peking University School of Oncology; Key Laboratory of Carcinogenesis and Translational Research; Ministry of Education; Beijing 100142; China
SHAO Bin; YU Jing; ZHU Yu-lin; ZHANG Jie; JIANG Han-fang; DI Li-jun; SONG Guo-hong; ZHU Bu- dong; CHE Li; JIA Jun; LIANG Xu; WANG Chao-ying; YAN Ying; Lü Min; LIN Xiao-lin; HUANG Xiao-lei; YOU Miao-ning; WANG Xiao-li; ZHOU Xin-na; REN Jun Department of Breast Oncology; Beijing Cancer Hospital & Beijing Institute for Cancer Research; Peking University School of Oncology; Key Laboratory of Carcinogenesis and Translational Research; Ministry of Education; Beijing 100142; China
..............page:334-338
..............page:385
The expressions of uPA and PAI-1 in patients with breast cancer and their clinical signicance
DONG Huan * ; LIN Yan-ping * ; YING Xue-xiang; HE Ping-qing Department of General Surgery; Sixth People’s Hospital; Shanghai Jiaotong University; Shanghai 200233; China
DONG Huan * ; LIN Yan-ping * ; YING Xue-xiang; HE Ping-qing Department of General Surgery; Sixth People’s Hospital; Shanghai Jiaotong University; Shanghai 200233; China
..............page:361-367
Advances in research on the role of clusterin in treatment of human malignancies
MA Xiao; LI He-cheng Department of Thoracic Surgery; Fudan University Shanghai Cancer Center; Department of Oncology; Shanghai Medical College of Fudan University; Shanghai 200032; China
MA Xiao; LI He-cheng Department of Thoracic Surgery; Fudan University Shanghai Cancer Center; Department of Oncology; Shanghai Medical College of Fudan University; Shanghai 200032; China
..............page:368-371
..............page:371
..............page:320
Advances in research of PARP inhibitors in combination with chemotherapeutic agents in the treatment of malignant tumors
HUANG He 1 ; CAO Yang 1 ; WU Ying-li 2 ; YAN Hua 1 1. Department of Hematology; Ruijin Hospital; Shanghai Jiaotong University School of Medicine; Shanghai 200025; China; 2. Department of Pathology; Shanghai Jiaotong University School of Medicine; Shanghai 20025; China
HUANG He 1 ; CAO Yang 1 ; WU Ying-li 2 ; YAN Hua 1 1. Department of Hematology; Ruijin Hospital; Shanghai Jiaotong University School of Medicine; Shanghai 200025; China; 2. Department of Pathology; Shanghai Jiaotong University School of Medicine; Shanghai 20025; China
..............page:372-377
K-ras gene mutation status in 454 Chinese patients with colorectal cancer
FAN Shao-an; YUAN Yi-wei; ZHAO Xin-tai Shanghai SHINES Pharmaceuticals Company Limited; Research Base of Molecular Diagnosis Technology for Tumor Peronalized Medicine; Development Center for Medical Science and Technology; Ministry of Health; Shanghai 200436; China
FAN Shao-an; YUAN Yi-wei; ZHAO Xin-tai Shanghai SHINES Pharmaceuticals Company Limited; Research Base of Molecular Diagnosis Technology for Tumor Peronalized Medicine; Development Center for Medical Science and Technology; Ministry of Health; Shanghai 200436; China
..............page:355-360
Glucose metabolism of lung adenocarcinoma A549 cells and its correlation with taxol-resistance
ZHAO Shi-yan; ZHOU Xiang; LI Jia-jin; HUANG Gang Department of Nuclear Medicine; Renji Hospital; Shanghai Jiaotong University School of Medicine; Shanghai 200127; China
ZHAO Shi-yan; ZHOU Xiang; LI Jia-jin; HUANG Gang Department of Nuclear Medicine; Renji Hospital; Shanghai Jiaotong University School of Medicine; Shanghai 200127; China
..............page:299-303
Bufalin reverses resistance to ge tinib in xenografts of lung adenocarcinoma H1975 cells in nude mice
KANG Xiao-hong 1; 2 ; GONG Ya-bin 1 ; WANG Li-fang 1 ; WANG Zhong-qi 1 ; XU-Ling 1 ; XU Zhen-ye 1 1. Department of Medical Oncology; Longhua Hospital; Shanghai University of Traditional Chinese Medicine; Shanghai 200032; China; 2. Department of Clinical Oncology; Pingdingshan First People’s Hospital; Pingdingshan 467000; He’nan Province; China
KANG Xiao-hong 1; 2 ; GONG Ya-bin 1 ; WANG Li-fang 1 ; WANG Zhong-qi 1 ; XU-Ling 1 ; XU Zhen-ye 1 1. Department of Medical Oncology; Longhua Hospital; Shanghai University of Traditional Chinese Medicine; Shanghai 200032; China; 2. Department of Clinical Oncology; Pingdingshan First People’s Hospital; Pingdingshan 467000; He’nan Province; China
..............page:304-308
Clinical and biological characteristics and the diagnosis and management of poorly-differentiated thyroid carcinoma
ZHAO Cui; LI Xiao-long; GAO Ming Department of Thyroid﹠and Neck Tumor; Tianjin Medical University Cancer Hospital; Tianjin Key Laboratory of Cancer Prevention and Therapy; Tianjin; 300060; China
ZHAO Cui; LI Xiao-long; GAO Ming Department of Thyroid﹠and Neck Tumor; Tianjin Medical University Cancer Hospital; Tianjin Key Laboratory of Cancer Prevention and Therapy; Tianjin; 300060; China
..............page:345-349
The construction and expression of Luffin-β-targeted fusion immunotoxin as well as its inhibitory effect on non-small cell lung cancer cells
XIANG Ying; LI Qi-ying; WANG Jiang-hong; WANG Li; HUANG De-hong; TANG Xian-jun; ZHANG Man; ZHANG Wen-jun; YANG Tao; XIAO Chun-yan Department of Bio-therapy and Hemato-oncology; Chongqing Cancer Institute; Chongqing 400030; China
XIANG Ying; LI Qi-ying; WANG Jiang-hong; WANG Li; HUANG De-hong; TANG Xian-jun; ZHANG Man; ZHANG Wen-jun; YANG Tao; XIAO Chun-yan Department of Bio-therapy and Hemato-oncology; Chongqing Cancer Institute; Chongqing 400030; China
..............page:314-320